Azevêdo AB, Sobral AP, Faria CA, Sousa JS, Silva WR, Silveira MM. Assessment of the prevalence of Behcet's disease in recurrent aphthous ulceration worldwide: a systematic review. Med Oral Patol Oral Cir Bucal. 2025 Jul 1;30 (4):e484-90.


doi:10.4317/medoral.27023

https://dx.doi.org/doi:10.4317/medoral.27023


1. Sánchez-Bernal J, Conejero C, Conejero R. Recurrent Aphthous Stomatitis. Actas Dermosifiliogr (Engl Ed). 2020;111:471-80

https://doi.org/10.1016/j.ad.2019.09.004

PMid:32451064 

2. Wang Z, Cao H, Xiong J, Lu Y, Deng Y, Nan H, et al. Recent advances in the aetiology of recurrent aphthous stomatitis (RAS). Postgrad Med J. 2022;98:57-66.

https://doi.org/10.1136/postgradmedj-2020-139421

PMid:33574180 

3. Naga SHA, Hassan LM, Zanaty RTE Refaat M, Amin RH, Gaafar R, et al, Behçet uveitis: Current practice and future perspectives. Front. Med. 2002;9:1-16.

PMid:36160151 PMCid:PMC9490079

4. Yaizici Y, Hatemi G, Bodaghi B, Cheon JH, Suziki N, Ambrose N, et al. Behçet syndrome (Primer). Nature Reviews: Disease Primers. 2021;7:1-14.

https://doi.org/10.1038/s41572-021-00301-1

PMid:34531393 

5. Novak T, Hamedi M, Bergmeier LA, Fortune F, Hagi-Pavli E. Saliva and serum cytokine profiles during oral ulceration in behçet's disease. Frontiers in immunology. 2021;12:1-20.

https://doi.org/10.3389/fimmu.2021.724900

PMid:35003055 PMCid:PMC8727526

6. Hatemi G, Mahr A, Takeno M, Saadoun D, Direskeneli H, Melikoğlu M, Direskeneli H, et al. Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial. Clin Exp Rheumatol. 2021;132:80-7.

https://doi.org/10.55563/clinexprheumatol/ra8ize

PMid:34622764 

7. Nakamura K, Iwata Y, Asai J, Kawakami T, Tsunemi Y, Takeuchi M, et al. Guidelines for the treatment of skin and mucosal lesions in Behçet's disease: A secondary publication. The Journal of Dermatology. 2020;47:223-35.

https://doi.org/10.1111/1346-8138.15207

PMid:31907947 

8. Idil A, Gürler A, Boyvat AYŞE, Caliskan D, Özdemir Ö, Isik A, et al. The prevalence of Behçet's disease above the age of 10 years The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic epidemiology. 2002;9:325-31.

https://doi.org/10.1076/opep.9.5.325.10338

PMid:12528917 

9. Davatchi F, AssaadKhalil S., Calamia KT, Crook JE, SadeghiAbdollahi B, Schirmer M, et al. The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. Journal of the european Academy of Dermatology and Venereology. 2014;28:338-47

https://doi.org/10.1111/jdv.12107

PMid:23441863 

10. Tunes RS, Anjos TC, Martins GB, Barreto ER, Santiago MB . Prevalence of Behcet's syndrome in patients with recurrent aphthous ulcerations in Brazil. Rheumatology International. 2009;29:875-8.

https://doi.org/10.1007/s00296-008-0787-1

PMid:19037605 

11. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. A declaração PRISMA 2020: diretriz atualizada para relatar revisões sistemáticas. Revista panamericana de salud publica. 2022;46:1-12.

https://doi.org/10.26633/RPSP.2022.112

PMid:36601438 PMCid:PMC9798848

12. Silva WR, Sobral APV, Romeiro K, Lima CRS, Isaltino MC, Telles CTV, Albuquerque DS. Proteins Associated with Persistent Apical Periodontitis: A Scoping Review. Iranian Endodontic Journal. 2024;19:254-62.

PMid:39469511

13. Baş Y, Seçkin HY, Kalkan G, Takcı Z, Önder Y, Çıtıl R, et al. Investigation of Behçet's disease and recurrent aphthous stomatitis frequency: the highest prevalence in Turkey. Balkan medical jornal. 2016;33:390-5.

https://doi.org/10.5152/balkanmedj.2016.15101

PMid:27606133 PMCid:PMC5001815

14. Jaber L, Milo G, Halpern GJ, Krause I, Weinberger A. Prevalence of Behçet's disease in an Arab community in Israel. Annals of the rheumatic diseases. 2002;61:365-6.

https://doi.org/10.1136/ard.61.4.365

PMid:11874845 PMCid:PMC1754053

15. P Klein P, Weinberger A, Altmann VJ, Halabi S, Fachereldeen S, Krause I. Prevalence of Behcet's disease among adult patients consulting three major clinics in a Druze town in Israel. Clinical rheumatology. 2010;29:1163-6.

https://doi.org/10.1007/s10067-010-1472-9

PMid:20467881 

16. Azizlerli G, Köse AA, Sarıca R, Gül A, Tutkun İT, Kulaç M, et al. Prevalence of Behçet's disease in Istanbul, Turkey. International journal of dermatology. 2003;42:803-6.

https://doi.org/10.1046/j.1365-4362.2003.01893.x

PMid:14521694 

17. Cakir N, Dervis E, Benian O, Pamuk ON, Sonmezates N, Rahimoglu R, et al. Prevalence of Behçet's disease in rural western Turkey: a preliminary report. Clinical and experimental rheumatology. 2004;22:53-55.

PMid:15515786

18. F Horie Y, Meguro A, Ohta T, Lee EB, Namba K, Mizuuchi K, Mizuuchi K, et al. HLA-B51 carriers are susceptible to ocular symptoms of Behçet disease and the association between the two becomes stronger towards the east along the silk road: a literature survey. Ocular Immunology and Inflammation. 2017;25:37-40

https://doi.org/10.3109/09273948.2015.1136422

PMid:26954704 

19. Akintoye SO, Greenberg MS. Recurrent aphthous stomatitis. Dental Clinics. 2014;58:281-97.

https://doi.org/10.1016/j.cden.2013.12.002